334 related articles for article (PubMed ID: 20482847)
21. Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells.
Honore S; Kamath K; Braguer D; Horwitz SB; Wilson L; Briand C; Jordan MA
Cancer Res; 2004 Jul; 64(14):4957-64. PubMed ID: 15256469
[TBL] [Abstract][Full Text] [Related]
22. Ansamitocin P3 depolymerizes microtubules and induces apoptosis by binding to tubulin at the vinblastine site.
Venghateri JB; Gupta TK; Verma PJ; Kunwar A; Panda D
PLoS One; 2013; 8(10):e75182. PubMed ID: 24124473
[TBL] [Abstract][Full Text] [Related]
23. PMA synergistically enhances apicularen A-induced cytotoxicity by disrupting microtubule networks in HeLa cells.
Seo KS; Kim JS; Park JH; Song KS; Yun EJ; Park JI; Kweon GR; Yoon WH; Lim K; Hwang BD
BMC Cancer; 2014 Jan; 14():36. PubMed ID: 24447339
[TBL] [Abstract][Full Text] [Related]
24. Dietary antioxidant curcumin inhibits microtubule assembly through tubulin binding.
Gupta KK; Bharne SS; Rathinasamy K; Naik NR; Panda D
FEBS J; 2006 Dec; 273(23):5320-32. PubMed ID: 17069615
[TBL] [Abstract][Full Text] [Related]
25. Microtubule dynamics, mitotic arrest, and apoptosis: drug-induced differential effects of betaIII-tubulin.
Gan PP; McCarroll JA; Po'uha ST; Kamath K; Jordan MA; Kavallaris M
Mol Cancer Ther; 2010 May; 9(5):1339-48. PubMed ID: 20442307
[TBL] [Abstract][Full Text] [Related]
26. Dietary flavonoid fisetin binds to β-tubulin and disrupts microtubule dynamics in prostate cancer cells.
Mukhtar E; Adhami VM; Sechi M; Mukhtar H
Cancer Lett; 2015 Oct; 367(2):173-83. PubMed ID: 26235140
[TBL] [Abstract][Full Text] [Related]
27. Dicoumarol: a unique microtubule stabilizing natural product that is synergistic with Taxol.
Madari H; Panda D; Wilson L; Jacobs RS
Cancer Res; 2003 Mar; 63(6):1214-20. PubMed ID: 12649179
[TBL] [Abstract][Full Text] [Related]
28. Identification of tubulin as the molecular target of proapoptotic pyrrolo-1,5-benzoxazepines.
Mulligan JM; Greene LM; Cloonan S; Mc Gee MM; Onnis V; Campiani G; Fattorusso C; Lawler M; Williams DC; Zisterer DM
Mol Pharmacol; 2006 Jul; 70(1):60-70. PubMed ID: 16571652
[TBL] [Abstract][Full Text] [Related]
29. Suppression of microtubule dynamics by binding of cemadotin to tubulin: possible mechanism for its antitumor action.
Jordan MA; Walker D; de Arruda M; Barlozzari T; Panda D
Biochemistry; 1998 Dec; 37(50):17571-8. PubMed ID: 9860873
[TBL] [Abstract][Full Text] [Related]
30. Genistein arrests cell cycle progression of A549 cells at the G(2)/M phase and depolymerizes interphase microtubules through binding to a unique site of tubulin.
Mukherjee S; Acharya BR; Bhattacharyya B; Chakrabarti G
Biochemistry; 2010 Mar; 49(8):1702-12. PubMed ID: 20085293
[TBL] [Abstract][Full Text] [Related]
31. Microtubule assembly dynamics: an attractive target for anticancer drugs.
Singh P; Rathinasamy K; Mohan R; Panda D
IUBMB Life; 2008 Jun; 60(6):368-75. PubMed ID: 18384115
[TBL] [Abstract][Full Text] [Related]
32. The novel microtubule-destabilizing drug BAL27862 binds to the colchicine site of tubulin with distinct effects on microtubule organization.
Prota AE; Danel F; Bachmann F; Bargsten K; Buey RM; Pohlmann J; Reinelt S; Lane H; Steinmetz MO
J Mol Biol; 2014 Apr; 426(8):1848-60. PubMed ID: 24530796
[TBL] [Abstract][Full Text] [Related]
33. Drug resistance associated with loss of p53 involves extensive alterations in microtubule composition and dynamics.
Galmarini CM; Kamath K; Vanier-Viornery A; Hervieu V; Peiller E; Falette N; Puisieux A; Ann Jordan M; Dumontet C
Br J Cancer; 2003 Jun; 88(11):1793-9. PubMed ID: 12771997
[TBL] [Abstract][Full Text] [Related]
34. Cyclostreptin binds covalently to microtubule pores and lumenal taxoid binding sites.
Buey RM; Calvo E; Barasoain I; Pineda O; Edler MC; Matesanz R; Cerezo G; Vanderwal CD; Day BW; Sorensen EJ; López JA; Andreu JM; Hamel E; Díaz JF
Nat Chem Biol; 2007 Feb; 3(2):117-25. PubMed ID: 17206139
[TBL] [Abstract][Full Text] [Related]
35. A new diaryl urea compound, D181, induces cell cycle arrest in the G1 and M phases by targeting receptor tyrosine kinases and the microtubule skeleton.
Zhang J; Zhou J; Ren X; Diao Y; Li H; Jiang H; Ding K; Pei D
Invest New Drugs; 2012 Apr; 30(2):490-507. PubMed ID: 21080210
[TBL] [Abstract][Full Text] [Related]
36. Eribulin binds at microtubule ends to a single site on tubulin to suppress dynamic instability.
Smith JA; Wilson L; Azarenko O; Zhu X; Lewis BM; Littlefield BA; Jordan MA
Biochemistry; 2010 Feb; 49(6):1331-7. PubMed ID: 20030375
[TBL] [Abstract][Full Text] [Related]
37. Multiple mechanisms underlying acquired resistance to taxanes in selected docetaxel-resistant MCF-7 breast cancer cells.
Wang H; Vo T; Hajar A; Li S; Chen X; Parissenti AM; Brindley DN; Wang Z
BMC Cancer; 2014 Jan; 14():37. PubMed ID: 24447372
[TBL] [Abstract][Full Text] [Related]
38. Vitamin K3 disrupts the microtubule networks by binding to tubulin: a novel mechanism of its antiproliferative activity.
Acharya BR; Choudhury D; Das A; Chakrabarti G
Biochemistry; 2009 Jul; 48(29):6963-74. PubMed ID: 19527023
[TBL] [Abstract][Full Text] [Related]
39. Effects of vinblastine, podophyllotoxin and nocodazole on mitotic spindles. Implications for the role of microtubule dynamics in mitosis.
Jordan MA; Thrower D; Wilson L
J Cell Sci; 1992 Jul; 102 ( Pt 3)():401-16. PubMed ID: 1506423
[TBL] [Abstract][Full Text] [Related]
40. Development of a novel class of tubulin inhibitor from desmosdumotin B with a hydroxylated bicyclic B-ring.
Nakagawa-Goto K; Oda A; Hamel E; Ohkoshi E; Lee KH; Goto M
J Med Chem; 2015 Mar; 58(5):2378-89. PubMed ID: 25695315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
